Webinars

Previous Webinars

Novel applications for Ex-vivo PDX models of the Tumor Microenvironment

Translational Oncology Virtual Summit held in September 2020

Presented by Veronica Sacchi, PhD, Scientist III, PhenoVista Biosciences

Watch now

Embracing variation: a multi-batch study delivers robust estimates of efficacy

Translational Oncology Virtual Summit held in September 2020

Presented by Natasha A Karp, PhD, Principal Biostatistician in Discovery Sciences, AstraZeneca

Watch now

Fast-tracking C010DS-Zn: PARP1-agonist targeting cancer and M2-like macrophages

Translational Oncology Virtual Summit held in September 2020

Presented by Jinhyuk Fred Chung, PhD, Chief Scientific Officer, Xylonix Pte. Ltd.

Watch now

High-Definition Spatial Proteomics for Characterizing the Tumor Microenvironment

Translational Oncology Virtual Summit held in September 2020

Presented by Jason Ptacek, PhD, Associate Director of Research Services, IONpath, Inc.

Watch now

Selective Ablation of Malignant Cells using Apoptotic Gene Therapy

Translational Oncology Virtual Summit held in September 2020

Presented by Jailal Ablack, PhD, Head of Preclinical Research, OncoSenX

Watch now

Evaluation of Acute Myeloid Leukemia by high parameter flow cytometry

Translational Oncology Virtual Summit held in September 2020

Presented by Greg Bannish, PhD, Flow Cytometry Subject Matter Expert, Champions Oncology

Watch now

Targeting IDH mutations in Cancer

Translational Oncology Virtual Summit held in September 2020

Presented by Brandon Nicolay, PhD, Associate Director, Pharmacology, Agios Pharmaceuticals

Watch now

Human-derived IO preclinical systems—from in vitro to in vivo and back

Translational Oncology Virtual Summit held in September 2020

Presented by Amy Wesa, PhD, Head of R&D, Champions Oncology

Watch now

Tipifarnib as a Precision Therapy for HRAS-Mutant Head and Neck SCCs

Translational Oncology Virtual Summit held in September 2020

Presented by Francis Burrows, PhD, VP of Translational Research, Kura Oncology

Watch now

Models for evaluating cancerous stem cell-targeting therapeutics

Translational Oncology Virtual Summit held in September 2020

Presented by Lynn Biderman, PhD, Senior Scientist, Stelexis Therapeutics

Watch now

Constrained bicyclic peptide delivery of toxin & immune agonists to solid tumors

Translational Oncology Virtual Summit held in September 2020

Presented by Johanna Lahdenranta, PhD, Director, In Vivo Pharmacology, Bicycle Therapeutics

Watch now

Cell cycle intervention beyond Palbociclib; discovery of a CDK2/4/6 inhibitor

Translational Oncology Virtual Summit held in September 2020

Presented by Stephen Dann, PhD, Associate Research Fellow, Pfizer

Watch now

Targeting Notch Altered Patient Derived Xenografts (PDX) with AL101

Translational Oncology Virtual Summit held in September 2020

Presented by Joel Kaye, PhD, VP Research & Nonclinical Development, Ayala Pharmaceuticals

Watch now

Novel Applications for Ex Vivo PDX Models of the Tumor Microenvironment

Presented by Chris Koehler, PhD, Director of Scientific Operations at PhenoVista Biosciences

Watch now

Myeloid Cell Conundrum in Inflammation and Cancer

Presented by Pravesh Gupta,PhD, Postdoctoral Fellow at Krishna Bhat's Lab at MD Anderson

Watch Now

LUMIN: Harnessing the Power of Pharmaco-omics to Illuminate Tumor Cell Biology

Presented by Michael Ritchie, PhD, MBA, Champions Oncology, Chief Commercial Officer

Watch Now

Flow Cytometry: Validation and Implementation in a Regulatory Setting

Presented by Chelsea Riveley, MBA, Head of Business Development, Flow Cytometry Services

Watch Now

It’s in the blood: Patient-Derived Hematologic Malignancy Models in Research

Presented by Amy Wesa, PhD, Director of Immuno-Oncology Research, Champions Oncology

Watch Now

Designing Cytometry Assays for Immuno-Oncology Applications: The Do’s, Don’ts & Don’t Forgets

Presented by Dr. Tamara Laskowski, Senior Research Scientist of MD Anderson Cancer Center

Watch Now

Next Generation Humanized Mice for AML and NK Cell Therapy Testing

Presented by Amy Wesa, PhD, Director of Immuno-Oncology Research

Watch Now

Advanced Hematology Oncology PDX Tumor Biology Platforms for Drug Advancement

Presented by Neal Goodwin, PhD, Vice President of Research Development

Watch Now

PDX Programs for Clinical Advancement of Oncology Agents

Presented by Neal Goodwin, PhD, Vice President of Research Development

Watch Now

Modeling the Human Immune System for Immuno-Oncology Drug Development

A Taconic Biosciences Webinar Series

Watch Now